Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts.

Liang Y, Mafuvadze B, Besch-Williford C, Hyder SM.

Breast Cancer (Dove Med Press). 2018 Mar 22;10:53-67. doi: 10.2147/BCTT.S156285. eCollection 2018.

2.

Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.

Goyette S, Liang Y, Mafuvadze B, Cook MT, Munir M, Hyder SM.

Breast Cancer (Dove Med Press). 2017 May 19;9:347-357. doi: 10.2147/BCTT.S135371. eCollection 2017.

3.

Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells.

Liang Y, Mafuvadze B, Aebi JD, Hyder SM.

Onco Targets Ther. 2016 May 30;9:3223-32. doi: 10.2147/OTT.S105725. eCollection 2016.

4.

The impact of traditional and religious practices on the spread of Ebola in West Africa: time for a strategic shift.

Manguvo A, Mafuvadze B.

Pan Afr Med J. 2015 Oct 10;22 Suppl 1:9. doi: 10.11694/pamj.supp.2015.22.1.6190. eCollection 2015. No abstract available.

5.

Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.

Cook MT, Mafuvadze B, Besch-Williford C, Ellersieck MR, Goyette S, Hyder SM.

Oncol Rep. 2016 Feb;35(2):825-32. doi: 10.3892/or.2015.4431. Epub 2015 Nov 17.

PMID:
26719029
6.

Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.

Cook MT, Liang Y, Besch-Williford C, Goyette S, Mafuvadze B, Hyder SM.

Springerplus. 2015 Aug 22;4:444. doi: 10.1186/s40064-015-1242-x. eCollection 2015.

7.

TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.

Fang WB, Mafuvadze B, Yao M, Zou A, Portsche M, Cheng N.

PLoS One. 2015 Aug 7;10(8):e0135063. doi: 10.1371/journal.pone.0135063. eCollection 2015.

8.

Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.

Mafuvadze B, Liang Y, Hyder SM.

Oncol Rep. 2014 Oct;32(4):1727-33. doi: 10.3892/or.2014.3332. Epub 2014 Jul 15.

PMID:
25051231
9.

Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.

Liang Y, Besch-Williford C, Aebi JD, Mafuvadze B, Cook MT, Zou X, Hyder SM.

Breast Cancer Res Treat. 2014 Jul;146(1):51-62. doi: 10.1007/s10549-014-2996-5. Epub 2014 May 31.

PMID:
24878988
10.

Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.

Mafuvadze B, Cook M, Xu Z, Besch-Williford CL, Hyder SM.

Nutr Cancer. 2013;65(8):1184-91. doi: 10.1080/01635581.2013.833637. Epub 2013 Oct 15.

PMID:
24127693
11.

Dental caries and oral health practice among 12 year old school children from low socio-economic status background in Zimbabwe.

Mafuvadze BT, Mahachi L, Mafuvadze B.

Pan Afr Med J. 2013 Apr 29;14:164. doi: 10.11604/pamj.2013.14.164.2399. Print 2013.

12.

Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.

Neubauer H, Ruan X, Schneck H, Seeger H, Cahill MA, Liang Y, Mafuvadze B, Hyder SM, Fehm T, Mueck AO.

Menopause. 2013 May;20(5):504-10. doi: 10.1097/GME.0b013e3182755c97.

PMID:
23615641
13.

Breast cancer knowledge and awareness among university students in Angola.

Sambanje MN, Mafuvadze B.

Pan Afr Med J. 2012;11:70. Epub 2012 Apr 16.

14.

Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.

Mafuvadze B, Liang Y, Besch-Williford C, Zhang X, Hyder SM.

Horm Cancer. 2012 Aug;3(4):160-71. doi: 10.1007/s12672-012-0114-x. Epub 2012 May 9.

PMID:
22569706
15.

Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model.

López Pérez FR, Liang Y, Besch-Williford CL, Mafuvadze B, Hyder SM.

Histol Histopathol. 2012 Mar;27(3):337-45. doi: 10.14670/HH-27.337.

PMID:
22237711
16.

Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.

Mafuvadze B, Benakanakere I, López Pérez FR, Besch-Williford C, Ellersieck MR, Hyder SM.

Cancer Prev Res (Phila). 2011 Aug;4(8):1316-24. doi: 10.1158/1940-6207.CAPR-10-0382. Epub 2011 Apr 19.

17.

Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells.

Mafuvadze B, Benakanakere I, Hyder SM.

Menopause. 2010 Sep-Oct;17(5):1055-63. doi: 10.1097/gme.0b013e3181dd052f.

PMID:
20551847

Supplemental Content

Loading ...
Support Center